Treatment adherence and risk of death after a myocardial infarction
Horwitz RI, Viscoli CM, Donaldson R, Murray C, Ransohoff D, Horwitz R, Berkman L, Horwitz S, Ransohoff D, Sindelar J. Treatment adherence and risk of death after a myocardial infarction. The Lancet 1990, 336: 542-545. PMID: 1975045, DOI: 10.1016/0140-6736(90)92095-y.Peer-Reviewed Original ResearchConceptsRisk of deathTreatment adherenceMyocardial infarctionPoor adherersBeta-Blocker Heart Attack TrialPost-infarction mortalityHeart Attack TrialGood adherersTreatment regimenAttack TrialClinical severitySociodemographic featuresInfarctionAdherersAdherenceDeathMortalityRiskSeverityPlaceboRegimenSmokingPatientsPropranololTrialsDifferences between women and men in survival after myocardial infarction. Biology or methodology?
Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction. Biology or methodology? JAMA 1990, 263: 1092-6. PMID: 2299781, DOI: 10.1001/jama.263.8.1092.Peer-Reviewed Original ResearchConceptsMyocardial infarctionMortality rateHospital survivorsRisk factorsPrevious heart failureHospital mortality rateRetrospective cohort studyIndependent risk factorObserved mortality rateHospital deathCohort studyMultivariate adjustmentHeart failureVentricular functionBaseline differencesSubsequent mortalityInfarctionMortalityWomenMenImpact of genderSurvivorsSurvivalHypertensionGender